サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1287601

単純ヘルペスウイルス治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Herpes Simplex Virus Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
単純ヘルペスウイルス治療市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年03月18日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

単純ヘルペスウイルス治療の世界市場規模は、2022年に25億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.2%の成長率（CAGR）を示し、2028年までに34億米ドルに達すると予測しています。

単純ヘルペスウイルス（HSV）は、唾液、精液、膣分泌物を通じて感染し、痛みを伴う水疱や潰瘍を引き起こす伝染性感染症です。一般的には、身体検査、体液採取、血液検査により診断されます。現在のところ、ファムシクロビル、アシクロビル、バラシクロビルなどの抗ウイルス薬が、患者さんにとって最も効果的な治療法となっています。これらの薬剤は、経口または静脈内投与により、症状の緩和、発症の頻度や重症度の軽減、ウイルスの感染防止に役立ちます。

単純ヘルペスウイルス治療の市場動向：

HSVは、ヒト免疫不全ウイルス（HIV）感染症の発症・感染リスクを高めるとともに、長期・慢性疾患のある人では、脳炎や角膜炎などの重篤な合併症を引き起こす可能性があります。このことは、慢性疾患を持つ人々の割合が増加していることと相まって、全世界でHSV治療の必要性を高めている重要な要因の一つとなっています。さらに、新生児ヘルペスは、出産時に乳児が生殖器内のHSVに感染することで発症する可能性のある重篤な疾患です。新生児ヘルペスは、乳児に永続的な神経学的障害や死亡を引き起こす可能性があるため、出生率の上昇が市場にプラスの影響を与えています。これとは別に、HSV感染の再活性化は一般的に骨髄および固形臓器移植の初期数ヶ月間に起こるため、臓器移植を受ける人の数が増加していることが市場の成長に貢献しています。これに伴い、研究者は口唇ヘルペスや性器ヘルペスの治療選択肢を広げるため、新しい抗ウイルス薬の開発に注力しています。さらに、HSVの灼熱感、かゆみ、ヒリヒリ感を和らげ、患者のQOLを向上させ、感染者がウイルスを拡散するのを防ぐ抗ウイルスクリームや軟膏も発表されています。

本レポートで回答した主な質問

  • 単純ヘルペスウイルス治療の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の単純ヘルペスウイルス治療市場に与えた影響は？
  • 主要な地域市場とは？
  • タイプに基づく市場の内訳は？
  • 薬剤の種類に基づく市場の内訳は？
  • 投与経路に基づく市場の内訳は？
  • 流通チャネルに基づく市場内訳は？
  • 業界のバリューチェーンにおける様々なステージは？
  • 業界における主要な促進要因と課題は何か？
  • 単純ヘルペスウイルス治療の世界市場の構造と主要プレイヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 単純ヘルペスウイルス治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 タイプ別市場内訳

  • 単純ヘルペスウイルス1型感染症
    • 市場動向
    • 市場予測
  • 単純ヘルペスウイルス2型感染症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 薬剤タイプ別市場内訳

  • アシクロビル
    • 市場動向
    • 市場予測
  • バラシクロビル
    • 市場動向
    • 市場予測
  • ファムシクロビル
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 投与経路別市場内訳

  • 経口剤
    • 市場動向
    • 市場予測
  • 注射剤
    • 市場動向
    • 市場予測
  • 外用剤
    • 市場動向
    • 市場予測

第9章 流通チャネル別市場内訳

  • 病院薬局
    • 市場動向
    • 市場予測
  • ドラッグストア
    • 市場動向
    • 市場予測
  • 小売店
    • 市場動向
    • 市場予測
  • オンラインファーマシー
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会（Opportunities
  • 脅威（Treats

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agenus Inc.
    • Apotex Inc.
    • Avet Pharmaceuticals Inc.
    • Carlsbad Tech
    • EPI Health LLC
    • F. Hoffmann-La Roche Ltd
    • Fresenius SE & Co. KGaA
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Novartis AG
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
図表

List of Figures

  • Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2022
  • Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
  • Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
  • Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
  • Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players
目次
Product Code: SR1623A359_Report

The global herpes simplex virus treatment market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.

Herpes simplex virus (HSV) is a contagious infection that can spread through saliva, semen, and vaginal secretions and cause painful blisters or ulcers. It is generally diagnosed through physical examinations, fluid sampling, and blood tests. At present, antiviral medications, such as famciclovir, acyclovir, and valacyclovir, are the most effective treatment options available for patients. These medications can be administered through oral or intravenous (IV) routes to help relieve symptoms, reduce the frequency and severity of outbreaks, and prevent the transmission of the virus.

Herpes Simplex Virus Treatment Market Trends:

HSV increases the risk of acquiring and transmitting human immunodeficiency virus (HIV) infection and can also lead to serious complications like encephalitis and keratitis in people with long-term or chronic illnesses. This, in confluence with the growing percentage of people with chronic diseases, represents one of the significant factors driving the need for HSV treatment across the globe. Moreover, neonatal herpes is a serious condition that can occur when an infant is exposed to HSV in the genital tract during delivery. As neonatal herpes can cause lasting neurologic disability or death in infants, the rising birth rates are influencing the market positively. Apart from this, as reactivation of HSV infection generally occurs during the initial months of bone marrow and solid-organ transplants, the increasing number of people undergoing organ transplantation is contributing to the market growth. In line with this, researchers are focusing on developing new antiviral medications to expand the treatment options for orolabial and genital herpes. In addition, they are introducing antiviral cream or ointment that can relieve burning, itching, or tingling sensations of HSV, improve the quality of life of patients, and prevent infected people from spreading the virus.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global herpes simplex virus treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, drug type, route of administration and distribution channel.

Breakup by Type:

Herpes Simples Virus-1 Infection

Herpes Simplex Virus-2 Infection

Others

Breakup by Drug Type:

Acyclovir

Valacyclovir

Famciclovir

Others

Breakup by Route of Administration:

Oral

Injectable

Topical

Breakup by Distribution Channel:

Hospital Pharmacy

Drug Stores

Retail Stores

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global herpes simplex virus treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global herpes simplex virus treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global herpes simplex virus treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Herpes Simplex Virus Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Herpes Simples Virus-1 Infection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Herpes Simplex Virus-2 Infection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Acyclovir
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Valacyclovir
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Famciclovir
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Online Pharmacy
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agenus Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Apotex Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Avet Pharmaceuticals Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Carlsbad Tech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 EPI Health LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Fresenius SE & Co. KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Glenmark Pharmaceuticals Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck & Co. Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novartis AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Teva Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Viatris Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials